These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
228 related articles for article (PubMed ID: 21829026)
1. Management of patients with hepatocellular carcinoma and extrahepatic metastasis. Lee HS Dig Dis; 2011; 29(3):333-8. PubMed ID: 21829026 [TBL] [Abstract][Full Text] [Related]
2. Role of intrahepatic tumor control in the prognosis of patients with hepatocellular carcinoma and extrahepatic metastases. Jung SM; Jang JW; You CR; Yoo SH; Kwon JH; Bae SH; Choi JY; Yoon SK; Chung KW; Kay CS; Jung HS J Gastroenterol Hepatol; 2012 Apr; 27(4):684-9. PubMed ID: 21916984 [TBL] [Abstract][Full Text] [Related]
3. Comparison of the effects of transarterial chemoembolization for advanced hepatocellular carcinoma between patients with and without extrahepatic metastases. Yoo JJ; Lee JH; Lee SH; Lee M; Lee DH; Cho Y; Lee YB; Yu SJ; Kim HC; Kim YJ; Yoon JH; Kim CY; Lee HS PLoS One; 2014; 9(11):e113926. PubMed ID: 25427152 [TBL] [Abstract][Full Text] [Related]
4. Clinical features of hepatocellular carcinoma with extrahepatic metastases. Natsuizaka M; Omura T; Akaike T; Kuwata Y; Yamazaki K; Sato T; Karino Y; Toyota J; Suga T; Asaka M J Gastroenterol Hepatol; 2005 Nov; 20(11):1781-7. PubMed ID: 16246200 [TBL] [Abstract][Full Text] [Related]
5. Hepatocellular carcinoma with extrahepatic metastasis: clinical features and prognostic factors. Uchino K; Tateishi R; Shiina S; Kanda M; Masuzaki R; Kondo Y; Goto T; Omata M; Yoshida H; Koike K Cancer; 2011 Oct; 117(19):4475-83. PubMed ID: 21437884 [TBL] [Abstract][Full Text] [Related]
6. Hepatocellular carcinoma with extrahepatic metastasis: Are there still candidates for transarterial chemoembolization as an initial treatment? Kim J; Sinn DH; Choi MS; Kang W; Gwak GY; Paik YH; Lee JH; Koh KC; Paik SW PLoS One; 2019; 14(3):e0213547. PubMed ID: 30845192 [TBL] [Abstract][Full Text] [Related]
7. Pre- and post- operative adjuvant targeting locoregional chemotherapy combined with locoregional targeting immunostimulation and surgical resection for hepatocellular carcinoma. A new promising alternative. Lygidakis NJ; Konstantinidou T; Pothoulakis J Anticancer Res; 1994; 14(3B):1351-5. PubMed ID: 8067704 [TBL] [Abstract][Full Text] [Related]
8. Exploring the role of resection of extrahepatic metastases from hepatocellular carcinoma. Chua TC; Morris DL Surg Oncol; 2012 Jun; 21(2):95-101. PubMed ID: 21397495 [TBL] [Abstract][Full Text] [Related]
9. Hepatocellular carcinoma 2009 and beyond: from the surveillance to molecular targeted therapy. Kudo M Oncology; 2008; 75 Suppl 1():1-12. PubMed ID: 19092266 [TBL] [Abstract][Full Text] [Related]
10. Screening for extrahepatic metastases by additional staging modalities is required for hepatocellular carcinoma patients beyond modified UICC stage T1. Yi J; Gwak GY; Sinn DH; Kim YJ; Kim HN; Choi MS; Lee JH; Koh KC; Paik SW; Yoo BC Hepatogastroenterology; 2013; 60(122):328-32. PubMed ID: 23241421 [TBL] [Abstract][Full Text] [Related]
12. Treatment of intermediate/advanced hepatocellular carcinoma in the clinic: how can outcomes be improved? Lencioni R; Chen XP; Dagher L; Venook AP Oncologist; 2010; 15 Suppl 4():42-52. PubMed ID: 21115580 [TBL] [Abstract][Full Text] [Related]
13. Management of hepatocellular carcinoma. Lau WY J R Coll Surg Edinb; 2002 Feb; 47(1):389-99. PubMed ID: 11874260 [TBL] [Abstract][Full Text] [Related]
14. Extrahepatic metastasis of hepatocellular carcinoma: incidence and risk factors. Kanda M; Tateishi R; Yoshida H; Sato T; Masuzaki R; Ohki T; Imamura J; Goto T; Yoshida H; Hamamura K; Obi S; Kanai F; Shiina S; Omata M Liver Int; 2008 Nov; 28(9):1256-63. PubMed ID: 18710423 [TBL] [Abstract][Full Text] [Related]
15. Locoregional therapies for hepatocellular carcinoma: which patients are most likely to gain a survival advantage? Mahady SE; Charlton B; Fitzgerald P; Koorey DJ; Perry JF; Waugh RC; McCaughan GW; Strasser SI J Gastroenterol Hepatol; 2010 Jul; 25(7):1299-305. PubMed ID: 20594260 [TBL] [Abstract][Full Text] [Related]
16. Systemic therapy of advanced hepatocellular carcinoma: how hopeful should we be? Zhu AX Oncologist; 2006; 11(7):790-800. PubMed ID: 16880238 [TBL] [Abstract][Full Text] [Related]
17. [A long-term survival case of hepatocellular carcinoma with bone metastasis and inferior vena cava tumor thrombus successfully treated with multidisciplinary therapy]. Yamada D; Wada H; Kobayashi S; Marubashi S; Eguchi H; Takeda Y; Tanemura M; Umeshita K; Doki Y; Mori M; Nagano H Gan To Kagaku Ryoho; 2010 Nov; 37(12):2670-2. PubMed ID: 21224675 [TBL] [Abstract][Full Text] [Related]
18. Patterns and clinicopathologic features of extrahepatic recurrence of hepatocellular carcinoma after curative resection. Yang Y; Nagano H; Ota H; Morimoto O; Nakamura M; Wada H; Noda T; Damdinsuren B; Marubashi S; Miyamoto A; Takeda Y; Dono K; Umeshita K; Nakamori S; Wakasa K; Sakon M; Monden M Surgery; 2007 Feb; 141(2):196-202. PubMed ID: 17263976 [TBL] [Abstract][Full Text] [Related]
19. Treatment for extrahepatic metastasis of hepatocellular carcinoma following successful hepatic resection. Aramaki M; Kawano K; Kai T; Yokoyama H; Morii Y; Sasaki A; Yoshida T; Kitano S Hepatogastroenterology; 1999; 46(29):2931-4. PubMed ID: 10576375 [TBL] [Abstract][Full Text] [Related]